Effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients

Abstract We investigated the effects of stent generation on 2-year clinical outcomes between prediabetes and diabetes patients after acute myocardial infarction (AMI). A total of 13,895 AMI patients were classified into normoglycemia (group A: 3673), prediabetes (group B: 5205), and diabetes (group...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yong Hoon Kim, Ae-Young Her, Myung Ho Jeong, Byeong-Keuk Kim, Sung-Jin Hong, Seunghwan Kim, Chul-Min Ahn, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5e470ac56bc54f8486b3d408ce566b40
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5e470ac56bc54f8486b3d408ce566b40
record_format dspace
spelling oai:doaj.org-article:5e470ac56bc54f8486b3d408ce566b402021-12-02T16:55:24ZEffects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients10.1038/s41598-021-88593-x2045-2322https://doaj.org/article/5e470ac56bc54f8486b3d408ce566b402021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88593-xhttps://doaj.org/toc/2045-2322Abstract We investigated the effects of stent generation on 2-year clinical outcomes between prediabetes and diabetes patients after acute myocardial infarction (AMI). A total of 13,895 AMI patients were classified into normoglycemia (group A: 3673), prediabetes (group B: 5205), and diabetes (group C: 5017). Thereafter, all three groups were further divided into first-generation (1G)-drug-eluting stent (DES) and second-generation (2G)-DES groups. Patient-oriented composite outcomes (POCOs) defined as all-cause death, recurrent myocardial infarction (Re-MI), and any repeat revascularization were the primary outcome. Stent thrombosis (ST) was the secondary outcome. In both prediabetes and diabetes groups, the cumulative incidences of POCOs, any repeat revascularization, and ST were higher in the 1G-DES than that in the 2G-DES. In the diabetes group, all-cause death and cardiac death rates were higher in the 1G-DES than that in the 2G-DES. In both stent generations, the cumulative incidence of POCOs was similar between the prediabetes and diabetes groups. However, in the 2G-DES group, the cumulative incidences of Re-MI and all-cause death or MI were significantly higher in the diabetes group than that in the prediabetes group. To conclude, 2G-DES was more effective than 1G-DES in reducing the primary and secondary outcomes for both prediabetes and diabetes groups.Yong Hoon KimAe-Young HerMyung Ho JeongByeong-Keuk KimSung-Jin HongSeunghwan KimChul-Min AhnJung-Sun KimYoung-Guk KoDonghoon ChoiMyeong-Ki HongYangsoo JangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yong Hoon Kim
Ae-Young Her
Myung Ho Jeong
Byeong-Keuk Kim
Sung-Jin Hong
Seunghwan Kim
Chul-Min Ahn
Jung-Sun Kim
Young-Guk Ko
Donghoon Choi
Myeong-Ki Hong
Yangsoo Jang
Effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients
description Abstract We investigated the effects of stent generation on 2-year clinical outcomes between prediabetes and diabetes patients after acute myocardial infarction (AMI). A total of 13,895 AMI patients were classified into normoglycemia (group A: 3673), prediabetes (group B: 5205), and diabetes (group C: 5017). Thereafter, all three groups were further divided into first-generation (1G)-drug-eluting stent (DES) and second-generation (2G)-DES groups. Patient-oriented composite outcomes (POCOs) defined as all-cause death, recurrent myocardial infarction (Re-MI), and any repeat revascularization were the primary outcome. Stent thrombosis (ST) was the secondary outcome. In both prediabetes and diabetes groups, the cumulative incidences of POCOs, any repeat revascularization, and ST were higher in the 1G-DES than that in the 2G-DES. In the diabetes group, all-cause death and cardiac death rates were higher in the 1G-DES than that in the 2G-DES. In both stent generations, the cumulative incidence of POCOs was similar between the prediabetes and diabetes groups. However, in the 2G-DES group, the cumulative incidences of Re-MI and all-cause death or MI were significantly higher in the diabetes group than that in the prediabetes group. To conclude, 2G-DES was more effective than 1G-DES in reducing the primary and secondary outcomes for both prediabetes and diabetes groups.
format article
author Yong Hoon Kim
Ae-Young Her
Myung Ho Jeong
Byeong-Keuk Kim
Sung-Jin Hong
Seunghwan Kim
Chul-Min Ahn
Jung-Sun Kim
Young-Guk Ko
Donghoon Choi
Myeong-Ki Hong
Yangsoo Jang
author_facet Yong Hoon Kim
Ae-Young Her
Myung Ho Jeong
Byeong-Keuk Kim
Sung-Jin Hong
Seunghwan Kim
Chul-Min Ahn
Jung-Sun Kim
Young-Guk Ko
Donghoon Choi
Myeong-Ki Hong
Yangsoo Jang
author_sort Yong Hoon Kim
title Effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients
title_short Effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients
title_full Effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients
title_fullStr Effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients
title_full_unstemmed Effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients
title_sort effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/5e470ac56bc54f8486b3d408ce566b40
work_keys_str_mv AT yonghoonkim effectsofstentgenerationonclinicaloutcomesafteracutemyocardialinfarctioncomparedbetweenprediabetesanddiabetespatients
AT aeyoungher effectsofstentgenerationonclinicaloutcomesafteracutemyocardialinfarctioncomparedbetweenprediabetesanddiabetespatients
AT myunghojeong effectsofstentgenerationonclinicaloutcomesafteracutemyocardialinfarctioncomparedbetweenprediabetesanddiabetespatients
AT byeongkeukkim effectsofstentgenerationonclinicaloutcomesafteracutemyocardialinfarctioncomparedbetweenprediabetesanddiabetespatients
AT sungjinhong effectsofstentgenerationonclinicaloutcomesafteracutemyocardialinfarctioncomparedbetweenprediabetesanddiabetespatients
AT seunghwankim effectsofstentgenerationonclinicaloutcomesafteracutemyocardialinfarctioncomparedbetweenprediabetesanddiabetespatients
AT chulminahn effectsofstentgenerationonclinicaloutcomesafteracutemyocardialinfarctioncomparedbetweenprediabetesanddiabetespatients
AT jungsunkim effectsofstentgenerationonclinicaloutcomesafteracutemyocardialinfarctioncomparedbetweenprediabetesanddiabetespatients
AT younggukko effectsofstentgenerationonclinicaloutcomesafteracutemyocardialinfarctioncomparedbetweenprediabetesanddiabetespatients
AT donghoonchoi effectsofstentgenerationonclinicaloutcomesafteracutemyocardialinfarctioncomparedbetweenprediabetesanddiabetespatients
AT myeongkihong effectsofstentgenerationonclinicaloutcomesafteracutemyocardialinfarctioncomparedbetweenprediabetesanddiabetespatients
AT yangsoojang effectsofstentgenerationonclinicaloutcomesafteracutemyocardialinfarctioncomparedbetweenprediabetesanddiabetespatients
_version_ 1718382862436139008